These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11782915)

  • 1. Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion.
    Kushida I; Ichikawa M; Asakawa N
    J Pharm Sci; 2002 Jan; 91(1):258-66. PubMed ID: 11782915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
    Kushida I; Gotoda M
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
    Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
    Chen Y; Zhang GG; Neilly J; Marsh K; Mawhinney D; Sanzgiri YD
    Int J Pharm; 2004 Nov; 286(1-2):69-80. PubMed ID: 15501003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
    Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
    Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
    Al-Hamidi H; Obeidat WM; Nokhodchi A
    Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
    Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
    Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.
    Lust A; Laidmäe I; Palo M; Meos A; Aaltonen J; Veski P; Heinämäki J; Kogermann K
    Eur J Pharm Sci; 2013 Jan; 48(1-2):47-54. PubMed ID: 23085546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion with hydroxypropylcellulose.
    Yamada T; Saito N; Anraku M; Imai T; Otagiri M
    Pharm Dev Technol; 2000; 5(4):443-54. PubMed ID: 11109244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
    Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
    Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
    Kang N; Lee J; Choi JN; Mao C; Lee EH
    Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.